03:28pm Wednesday 16 October 2019

High quality of global health research in Norway

 Vaccination in Burkina Faso.
Vaccination in Burkina Faso. The evaluation panel states that Norway has unique possibilities in this area, in particular because of its political commitment and role in global health.

 During the evaluation process, the panel saw evidence of some units performing very impressive research in the area of health problems in low- and middle-income countries, mainly in Sub-Saharan Africa, but also in Southeast Asia and South America.

Great contributions
“In spite of the small size of Norway, some of the research units have made great contributions. In particular, a number of units had very well developed strategies and suitable long-term impressive visions, “states the evaluation.


Foto: Shutterstock Foto: ShutterstockThe panel notes that the leading units in this field fully understood the importance of developing global health research as real partnerships, in which local collaborators were fully involved.

The evaluation finds that the best units had mechanisms in place, so that PhD students from the research areas, who had spent time at research units in Norway, really return to their original country, to use their new knowledge in local activities.

Requires long-term funding
The panel emphasizes that research activities overseas with implementation in preventive activities, require units with sufficient size and long-term funding.

They mention that “some successful research units, in particular in the fields of epidemiology and global health, would be able to make very good use of additional resources. This would benefit research in these areas, and be of practical use to Norway and other countries. At the least, this should be carefully considered by Research Council of Norway in the relative distribution of funding,” states the panel.

The Research Council of Norway’s Programme for Global Health and Vaccination Research (GLOBVAC) has recently been extended until 2020. “This gives us a chance to think long-term, “says Mari Nes, Director at the Research Council of Norway.

During the 2012-2020 period, in the order of NOK 600 million will be allocated to projects under the GLOBVAC programme.

  Effective strategies for collaboration
Foto: GLOBVACThe evaluation recommends that “The good and effective strategies for collaboration, developed by some units over a considerable period of time”, deserve to be
disseminated to other units active in the global health area, not only in Norway, but also internationally.

“We are very pleased with these findings. The best research environments have been good in building research capacity over time, and have managed to establish real and equal partnerships with researchers in low- and middle income countries, “ says Dr Nes.

“We now hope that most research institutions will commit themselves to long-term investments in this area,” adds Dr Nes.

Written by:
Siv Haugan

Share on:

MORE FROM Public Health and Safety

Health news